Table 1 Viability % of Vero cell line after treatment with different concentrations of G. glabra extract, L. acidophilus suspension, L. acidophilus supernatant and combination of L. acidophilus and G. glabra extract
Conc. of G. glabra mg/ml | Viability % | Conc. of L. acidophilus suspension mg/ml | Viability % | Conc. of L. acidophilus supernatant mg/ml | Viability % | Conc. of combination of L. acidophilus and G. glabra extract mg/ml | Viability % |
|---|---|---|---|---|---|---|---|
1.71 | 30.5 | 12.30 | 39.3 | 34.00 | 33.0 | 17.89 | 10.0 |
0.9 | 61.2 | 6.20 | 56.7 | 17.00 | 64.0 | 8.9 | 25.8 |
0.43 | 65.5 | 3.08 | 61.1 | 8.50 | 66.6 | 4.47 | 60.4 |
0.21 | 73.4 | 1.54 | 67.8 | 4.25 | 69.0 | 2.24 | 65.8 |
0.11 | 75.6 | 0.77 | 72.9 | 2.13 | 67.2 | 1.12 | 80.5 |
0.05 | 78.8 | 0.38 | 77.8 | 1.06 | 69.8 | 0.56 | 99.6 |
0.03 | 79.1 | 0.19 | 82.4 | 0.53 | 77.6 | 0.28 | 93.8 |
0.01 | 104.3 | 0.10 | 100.0 | 0.27 | 111.9 | 0.14 | 109.9 |
Working safe conc. mg/mL | |||||||
0.9 | 3.08 | 17.00 | 4.47 | ||||